Inventors list

Agents list

Assignees list

List by place

Classification tree browser

Top 100 Inventors

Top 100 Agents

Top 100 Assignees

ABBOTT LABORATORIES

ABBOTT PARK, IL US

1. 20090286784 INDAZOLE, BENZISOXAZOLE, AND BENZISOTHIAZOLE KINASE INHIBITORS 11-19-2009
2. 20090285881 CATIONIC LIPIDS AND USES THEREOF - Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using 11-19-2009
3. 20090282932 GAS SCRUBBER FOR AUTOMATED CLINICAL ANALYZER 11-19-2009
4. 20090275062 METHOD OF TACROLIMUS EXTRACTION AND QUANTIFICATION USING AQUEOUS DETERGENTS 11-05-2009
5. 20090273121 CLOSURE FOR CONTAINER FOR HOLDING BIOLOGICAL SAMPLES 11-05-2009
6. 20090270408 AMIDE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS AND METHODS OF USE THEREOF 10-29-2009
7. 20090270364 SUBSTITUTED PYRIMIDINE DERIVATIVES - The present application describes substituted pyrimidine compounds of formula STR00001 wherein X, A 10-29-2009
8. 20090263894 ANTIBODIES THAT BIND TO MAMMALIAN NGAL AND USES THEREOF 10-22-2009
9. 20090263845 METHOD AND KIT FOR ASSESSING THE SUITABILITY OF ERYTHROCYTES FOR TRANSFUSION 10-22-2009
10. 20090263477 SALTS OF FENOFIBRIC ACID AND PHARMACEUTICAL FORMULATIONS THEREOF 10-22-2009
11. 20090263407 Cationic Lipids and Uses Thereof - Cationic lipids, cationic lipid based drug delivery systems, ways to make them and methods of treating diseases using 10-22-2009
12. 20090258907 COMPOUNDS USEFUL AS INHIBITORS OF ROCK KINASES 10-15-2009
13. 20090254051 DEVICE AND METHOD FOR TREATING VULNERABLE PLAQUE 10-08-2009
14. 20090253723 PROTEIN KINASE INHIBITORS - Compounds that inhibit protein kinases compositions containing the compounds and methods of treating diseases using the 10-08-2009
15. 20090253678 MACROCYCLIC PYRIMIDINE DERIVATIVES - Macrocyclic pyrimidine compounds compositions comprising such compounds methods for making the compounds 10-08-2009
16. 20090253670 AMIDE DERIVATIVES AS POSITIVE ALLOSTERIC MODULATORS AND METHODS OF USE THEREOF 10-08-2009
17. 20090252652 Apparatus And Method For Handling Fluids For Analysis 10-08-2009
18. 20090246777 ALLELIC DISCRIMINATION ANALYSIS USING AN EFFICIENCY RELATED VALUE (EFR) 10-01-2009
19. 20090239271 FERMENTATION BROTH EXTRACTION OF K-252A - Methods for separating K-252a from the cell mass of its parent fermentation broth are disclosed 09-24-2009
20. 20090238766 BIOLUMINESCENT CONSTRUCT - construct comprising an amino acid sequence attached to a luciferin substrate 09-24-2009
21. 20090238436 COMPOSITION FOR IMAGING REAGENT - composition comprising a buffer and an aminoluciferase bioluminescent imaging reagent 09-24-2009
22. 20090233953 ANTAGONISTS OF THE VANILLOID RECEPTOR SUBTYPE 1 (VR1) AND USES THEREOF 09-17-2009
23. 20090232797 PLASMODIUM MALARIAE AND PLASMODIUM OVALE GENES AND USES THEREOF 09-17-2009
24. 20090221648 COMPOSITIONS FOR TREATMENT OF COGNITIVE DISORDERS 09-03-2009
25. 20090210046 HANDLE ASSEMBLY FOR A DELIVERY SYSTEM - delivery system incorporating a belt for accomplishing relative movement between components of the system 08-20-2009
26. 20090203842 Macromolecular Conjugates And Processes For Preparing The Same 08-13-2009
27. 20090203709 Pharmaceutical Dosage Form For Oral Administration Of Tyrosine Kinase Inhibitor 08-13-2009
28. 20090203690 5-SUBSTITUTED INDAZOLES AS KINASE INHIBITORS 08-13-2009
29. 20090203671 METHOD OF TREATING CANCER - Methods of treating cancer in patients comprising administering thereto aurora kinase inhibitors and TRAIL -related 08-13-2009
30. 20090203664 (1S,5S)-3-(5,6-DICHLORO-3-PYRIDINYL)-3,6- DIAZABICYCLO[3.2.0]HEPTANE 08-13-2009
31. 20090192141 METHODS OF USE OF INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME 07-30-2009
32. 20090181160 METHODS FOR APPLYING AN APPLICATION MATERIAL TO AN IMPLANTABLE DEVICE 07-16-2009
33. 20090181159 METHODS FOR APPLYING AN APPLICATION MATERIAL TO AN IMPLANTABLE DEVICE 07-16-2009
34. 20090176883 TRPA1 Antagonists - Compounds of formula STR00001 wherein R 07-09-2009
35. 20090176784 ANTI-INFECTIVE AGENTS AND USES THEREOF - This invention relates to: compounds and salts thereof that inter alia inhibit HCV 07-09-2009
36. 20090176783 INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME 07-09-2009
37. 20090176274 GLYCOSYLATED MAMMALIAN NGAL AND USE THEREOF 07-09-2009
38. 20090175847 HUMANIZED ANTIBODIES TO AB (20-42) GLOBULOMER AND USES THEREOF 07-09-2009
39. 20090165898 FATIGUE-RESISTANT NICKEL-TITANIUM ALLOYS AND MEDICAL DEVICES USING SAME 07-02-2009
40. 20090163470 THIAZOLYLIDINE UREA AND AMIDE DERIVATIVES AND METHODS OF USE THEREOF 06-25-2009
41. 20090162876 MYELOPEROXIDASE ASSAYS - methods and kits for determining autoantibodies to myeloperoxidase or a myeloperoxidase fragment and myeloperoxidase or a 06-25-2009
42. 20090160654 ARTICLES CONTAINING CHIPLESS RADIO FREQUENCY IDENTIFICATION ELEMENTS 06-25-2009
43. 20090158863 AUTOMATIC LOADING OF SAMPLE TUBES FOR CLINICAL ANALYZER 06-25-2009
44. 20090157168 METHOD AND APPARATUS FOR REDUCING THE SIZE OF AN ENDOPROSTHESIS 06-18-2009
45. 20090157105 ARTICULATING SUTURING DEVICE AND METHOD - method for closing an opening in tissue using a suturing device includes inserting at least a portion of a 06-18-2009
46. 20090157103 MODULAR CLIP APPLIER - apparatus for placement into an opening formed in a wall of a body lumen to deploy a closure element 06-18-2009
47. 20090157102 CLIP APPLIER AND METHODS OF USE - apparatus for placement into an opening formed in a wall of a body lumen to deploy a closure element 06-18-2009
48. 20090157101 TISSUE CLOSURE SYSTEM AND METHODS OF USE 06-18-2009
49. 20090157100 SYSTEM, METHOD AND DEVICE FOR CLOSING AN OPENING 06-18-2009
50. 20090157089 APPARATUS FOR LOADING AN IMPLANTABLE DEVICE 06-18-2009
51. 20090156929 METHODS FOR IMAGING A DELIVERY SYSTEM - method for imaging a delivery system is disclosed 06-18-2009
52. 20090155449 MEDICAL DEVICE COATING APPARATUS AND METHODS OF USE 06-18-2009
53. 20090151416 APPARATUS AND METHODS FOR MEDICAL DEVICE EXPANSION 06-18-2009
54. 20090149501 NOVEL INDOLES ARE CANNABINOID RECEPTOR LIGANDS 06-11-2009
55. 20090149461 METHOD OF TREATING CANCER - Methods of treating cancer using N--5 5-dimethyl-1-cyclohex-1-en-1-yl)methyl)pip- erazin-1-yl)benzoyl)-4--3--1-methyl- 06-11-2009
56. 20090142765 METHOD AND APPARATUS FOR RAPIDLY COUNTING AND IDENTIFYING BIOLOGICAL PARTICLES IN A FLOW STREAM 06-04-2009
57. 20090138048 INSTRUMENT FOR TENSIONING A FLEXIBLE TIE 05-28-2009
58. 20090137585 N-ACYLSULFONAMIDE APOPTOSIS PROMOTERS - N-Benzoyl arylsulfonamides having the formula STR00001 are BCL-Xl inhibitors and are useful for promoting 05-28-2009
59. 20090131434 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme 05-21-2009
60. 20090131379 VITAMIN D RECEPTOR ACTIVATORS AND METHODS OF MAKING 05-21-2009
61. 20090129990 RACK FOR SAMPLE CONTAINERS FOR CLINICAL ANALYZER 05-21-2009
62. 20090124934 GUIDEWIRE TORQUE DEVICE - In accordance with the present invention there is provided a guidewire torquing device configured to be readily attachable and 05-14-2009
63. 20090124815 Crystalline Chemotherapeutic - N-[4-phenyl]-N'-urea Crystalline Form 1 ways to make it formulations comprising it and made with it and methods of 05-14-2009
64. 20090124671 TRPV1 ANTAGONISTS - compounds of formula STR00001 wherein X, R 05-14-2009
65. 20090124666 TRPV1 ANTAGONISTS - Compounds of formula STR00001 wherein R 05-14-2009
66. 20090123970 GLYCOSYLATED MAMMALIAN NGAL AND USE THEREOF 05-14-2009
67. 20090123946 IMMUNOASSAYS AND KITS FOR THE DETECTION OF NGAL 05-14-2009
68. 20090123945 CHOLINERGIC/SEROTONINERGIC RECEPTOR AND USES THEREOF 05-14-2009
69. 20090123473 HUMAN BNP IMMUNOSPECIFIC ANTIBODIES - antibodies that immunospecifically bind to human brain natriuretic peptide or a human brain natriuretic peptide 05-14-2009
70. 20090118344 Crystalline Chemotherapeutic - N-[4-phenyl]-N'-urea Hydrate Crystalline Form 1 ways to make it formulations comprising it and made with it and methods 05-07-2009
71. 20090117620 AUTOMATED ANALYZER FOR CLINICAL LABORATORY 05-07-2009
72. 20090117004 SYSTEM FOR AUTOMATICALLY LOADING IMMUNOASSAY ANALYZER 05-07-2009
73. 20090111133 Gel Filtration Standard - suitable for use as molecular weight markers for gel filtration chromatography for a mobile phase with denaturant 04-30-2009
74. 20090105486 Crystalline Chemotherapeutic - N-phenyl)-N'-urea Tolueneate Crystalline Form 1, ways to make it and ways to use it are disclosed 04-23-2009
75. 20090105326 Crystalline Chemotherapeutic - N-[4-phenyl]-N'-urea1/4 Ethanolate Crystalline Form 1 ways to make it formulations comprising it and made with it and 04-23-2009
76. 20090105306 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 04-23-2009
77. 20090105304 COMBINATION THERAPY FOR REDUCING SIDE EFFECTS USING CANNABINOID RECEPTOR LIGANDS 04-23-2009
78. 20090099246 2-{(R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 2 04-16-2009
79. 20090099245 2-{(R)-2-METHYLPYRROLIDIN-2-YL)-1H-BENZIMIDAZOLE-4-CARBOXAMIDE CRYSTALLINE FORM 1 04-16-2009
80. 20090093875 DRUG ELUTING STENTS WITH PROLONGED LOCAL ELUTION PROFILES WITH HIGH LOCAL CONCENTRATIONS AND LOW SYSTEMIC CONCENTRATIONS 04-09-2009
81. 20090076590 ENDOPROSTHESES WITH STRUT PATTERN HAVING MULTIPLE STRESS RELIEVERS 03-19-2009
82. 20090062345 AMIDE DERIVATIVES AS TRPV1 ANTAGONISTS - compounds of formula or pharmaceutically acceptable salts prodrugs 03-05-2009
83. 20090054426 TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS 02-26-2009
84. 20090054420 BICYCLIC-SUBSTITUTED AMINES AS HISTAMINE-3 RECEPTOR LIGANDS 02-26-2009
85. 20090048615 DEVICE AND METHOD FOR SUTURING INTRACARDIAC DEFECTS 02-19-2009
86. 20090048298 Novel acetyl-CoA Carboxylase (ACC) Inhibitors and their use in Diabetes, Obesity and Metabolic Syndrome 02-19-2009
87. 20090036906 SUTURING DEVICE WITH SPLIT ARM AND METHOD OF SUTURING TISSUE 02-05-2009
88. 20090030016 BENZIMIDAZOLE POLY(ADP RIBOSE)POLYMERASE INHIBITORS 01-29-2009
89. 20090029966 COMBINATION THERAPY WITH PARP INHIBITORS 01-29-2009
90. 20090024157 EMBOLIC PROTECTION DEVICE WITH OPEN CELL DESIGN 01-22-2009
91. 20090018114 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 01-15-2009
92. 20090017560 CARDIOVASCULAR AUTOIMMUNE DISEASE PANEL AND METHODS OF USING SAME 01-15-2009
93. 20090011078 NUTRITIONAL COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING OSTEOPOROSIS 01-08-2009
94. 20090005856 ENDOPROSTHESES FOR PERIPHERAL ARTERIES AND OTHER BODY VESSELS 01-01-2009
95. 20080319475 Methods, Devices, and Apparatus for Managing Access Through Tissue 12-25-2008
96. 20080319458 SYSTEM FOR CLOSING A PUNCTURE IN A VESSEL WALL 12-25-2008
97. 20080312686 ANTIMICROBIAL CLOSURE ELEMENT AND CLOSURE ELEMENT APPLIER 12-18-2008
98. 20080312666 CLIP APPLIER AND METHODS OF USE - apparatus for delivering a closure element can include a splittable carrier tube and a splitter to split the tube 12-18-2008
99. 20080312458 Reactivity of Hydroxymethylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors Containing Conjugated Dienes with Phenolic Antioxidants in the Solid-State 12-18-2008
100. 20080312282 Inhibitors of Diacylglycerol O-acyltransferase Type 1 Enzyme 12-18-2008
101. 20080312214 Inhibitors of the 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Enzyme 12-18-2008
102. 20080311676 IMMUNOASSAYS EXHIBITING REDUCED CROSS-REACTIVITY WITH HYDROPHOBIC DRUG ANALYTE METABOLITES 12-18-2008
103. 20080300628 Medical Devices - medical system may include a medical device, such as a medical connector 12-04-2008
104. 20080299583 METHOD AND SYSTEM FOR ANALYZING REACTIONS USING AN INFORMATION SYSTEM 12-04-2008
105. 20080299567 PRIMER AND PROBE SEQUENCES FOR DETECTING CHLAMYDIA TRACHOMATIS 12-04-2008
106. 20080287923 Loading a Tissue Closure Device onto a Delivery Device 11-20-2008
107. 20080287675 CASCADE SYSTEM - method of purifying an active pharmaceutical ingredient sufficient for administration into a human subject can include: obtaining a 11-20-2008
108. 20080281348 MEDICAL DEVICES - At least a portion of the medical device may be guided to a desired position within a patient 11-13-2008
109. 20080281251 Medical Devices - medical device may be constructed using one or more components 11-13-2008
110. 20080279859 NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF 11-13-2008
111. 20080275048 Substituted Diazabicycloalkane Derivates 11-06-2008
112. 20080269236 Novel 1,2,4 Oxadiazole Compounds and Methods of Use Thereof 10-30-2008
113. 20080269234 INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE 10-30-2008
114. 20080255604 EMBOLIC PROTECTION DEVICE WITH LOCKING DEVICE 10-16-2008
115. 20080255180 4-Substituted Azaadamantane Derivatives and Methods of Use Thereof 10-16-2008
116. 20080255179 Acetamide and Carboxamide Derivatives of Azaadamantane and Methods of Use Thereof 10-16-2008
117. 20080255178 Azaadamantane Ester and Carbamate Derivatives and Methods of Use Thereof 10-16-2008
118. 20080254100 METHODS OF USING GAMMA CYCLODEXTRIN TO CONTROL BLOOD GLUCOSE AND INSULIN SECRETION 10-16-2008
119. 20080248579 Method of stabilizing human natriuretic peptides 10-09-2008
120. 20080242654 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS 10-02-2008
121. 20080241832 METHOD OF DETECTING AND QUANTIFYING HEPATITIS C VIRUS 10-02-2008
122. 20080214914 ANALYTE MONITORING DEVICE AND METHODS OF USE 09-04-2008
123. 20080214524 FUSED AZABICYCLIC COMPOUNDS THAT INHIBIT VANILLOID RECEPTOR SUBTYPE 1 (VR1) RECEPTOR 09-04-2008
124. 20080213797 IMMUNOASSAYS EXHIBITING A REDUCTION IN PROZONE PHENOMENA 09-04-2008
125. 20080210557 SUBCUTANEOUS GLUCOSE ELECTRODE - small diameter flexible electrode designed for subcutaneous in vivo amperometric monitoring of glucose is described 09-04-2008